Background: Genetic analysis for germline mutations in the RET proto-oncogene has provided a basis for the individual management of medullary thyroid carcinoma (MTC) and phaeochromcytoma.While the different phenotypes between compound trans/ cis mutation and single point mutation have been reported.But the relative data is still not enough.